*ST和科(002816) - 2024 Q4 - 年度业绩预告

Financial Performance Expectations - The company expects a net profit loss between RMB 36 million and RMB 58 million for the fiscal year 2024, compared to a loss of RMB 62.58 million in the previous year[4]. - Total revenue is projected to be between RMB 90 million and RMB 110 million, down from RMB 144.04 million in the same period last year[4]. - The company anticipates a loss of RMB 42 million to RMB 64 million for net profit after deducting non-recurring gains and losses, compared to a loss of RMB 79.84 million last year[4]. - Basic earnings per share are expected to be between RMB -0.36 and RMB -0.58, compared to RMB -0.63 in the previous year[4]. Financial Adjustments and Measures - The company has restructured receivables from Shenzhen Huihefu Enterprise Management Co., with an estimated impact on net profit of approximately RMB -4 million to RMB 4.5 million for 2024[7]. - The company has implemented cost control measures, resulting in a reduction of management expenses compared to the previous year[7]. - The company’s operating revenue structure has adjusted, leading to a slight decline in revenue compared to the same period last year[7]. Regulatory and Compliance Issues - The company warns that if the audited financial results show a net loss and revenue below RMB 300 million, it may face delisting risk warnings[8]. - The company emphasizes that the financial data provided is preliminary and subject to final audit confirmation[8]. - The company will continue to comply with information disclosure obligations as per the Shenzhen Stock Exchange regulations[8].